PE20060569A1 - Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc - Google Patents

Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc

Info

Publication number
PE20060569A1
PE20060569A1 PE2005000809A PE2005000809A PE20060569A1 PE 20060569 A1 PE20060569 A1 PE 20060569A1 PE 2005000809 A PE2005000809 A PE 2005000809A PE 2005000809 A PE2005000809 A PE 2005000809A PE 20060569 A1 PE20060569 A1 PE 20060569A1
Authority
PE
Peru
Prior art keywords
alkyl
indol
het
compounds
amino
Prior art date
Application number
PE2005000809A
Other languages
English (en)
Inventor
Pierre Louis Beaulieu
Christian Brochu
Jean Rancourt
Bounkham Thavonekham
Youla S Tsantrizos
Timothy A Stammers
Stephen Kawai
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35784831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20060569(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20060569A1 publication Critical patent/PE20060569A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

SE REFIERE A COMPUESTOS DE INDOL FORMULA (I), EN DONDE A O B SON INDISTINTAMENTE N Y C, LAS LINEAS PUNTEADAS REPRESENTAN UN DOBLE ENLACE SI ESTA ENTRE DOS CARBONOS Y SIMPLE SI ESTA ENTRE C Y N; R1 ES H O ALQUILO(C1-C6); R2 ES ALQUILO(C1-C6), ARILO O Het OPCIONALMENTE SUSTITUIDO CON R21, DONDE Het ES UN HETEROCICLO MONOCICLICO AROMATICO DE 5 A 6 MIEMBROS DE 1 A 4 HETEROATOMOS DE O, N O S Y OPCIONALMENTE CONDENSADO A OTRO CICLO; R3 ES CICLOALQUILO(C5-C6); R5 ES ALQUILO(C1-C6), ALQUENILO(C1-C6), Het, Het-ALQUILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS; R6 ES H, ALQUILO, HALO, ENTRE OTROS O R5 Y R6 PUEDEN ESTAR ENLAZADOS; R7 ES H, ALQUILO O ALCOXI(C1-C6), ENTRE OTROS; R9 Y R10 SON INDEPENDIENTEMENTE ALQUILO(C1-C6) O JUNTOS UNIDOS COVALENTEMENTE FORMAN UN CICLOAQUILO O CICLOALQUENILO(C5-C6), HETEROCICLO DE 5 A 6 MIEMBROS. SON PREFERIDOS: (E)-3-[4-({1-[(3-CICLOPENTIL-1-METIL-2-PIRIDIN-2-IL-1H-INDOL-6-CARBONIL)-AMINO]CICLOBUTANOLCARBONIL}AMINO)-2,6-DIMETOXIFENIL]ACRILICO, ACIDO (E)-3-{4-[(1-{[2-(5-CLORO-PIRIMIDIN-2-IL)-3-CICLOPENTIL-1-METIL-1H-INDOL-6-CARBONIL]-AMINO}CICLOBUTANOCARBONIL)AMINO]2-ETOXI-FENIL}-ACRILICO, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE ADEMAS PUEDE COMPRENDER OTRO AGENTE ANTIVIRAL COMO RIBAVIRINA, AMANTADINA, INMUNOMODULADORES, INHIBIDOR DE PROTEASA NE3 DE VHC, ENTRE OTROS. ESTOS COMPUESTOS SON INHIBIDORES DE ARN POLIMERASA DEPENDIENTE DE ARN DE LA ENZIMA NE5B, CODIFICADA POR VHC Y SON UTILES EN LA INFECCION POR VHC
PE2005000809A 2004-07-16 2005-07-14 Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc PE20060569A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58867004P 2004-07-16 2004-07-16

Publications (1)

Publication Number Publication Date
PE20060569A1 true PE20060569A1 (es) 2006-06-22

Family

ID=35784831

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000809A PE20060569A1 (es) 2004-07-16 2005-07-14 Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc

Country Status (19)

Country Link
US (2) US7241801B2 (es)
EP (1) EP1771442A4 (es)
JP (1) JP2008506638A (es)
KR (1) KR20070035092A (es)
CN (1) CN1984908A (es)
AR (1) AR050172A1 (es)
AU (1) AU2005263135A1 (es)
BR (1) BRPI0513431A (es)
CA (1) CA2573210A1 (es)
EA (1) EA200700038A1 (es)
EC (1) ECSP077171A (es)
IL (1) IL180665A0 (es)
MX (1) MX2007000007A (es)
NO (1) NO20070368L (es)
PE (1) PE20060569A1 (es)
TW (1) TW200617003A (es)
UY (1) UY29017A1 (es)
WO (1) WO2006007693A1 (es)
ZA (1) ZA200609578B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335700A1 (en) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US20050075279A1 (en) * 2002-10-25 2005-04-07 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7098231B2 (en) * 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
UA86962C2 (en) * 2004-02-20 2009-06-10 Бёрингер Ингельхайм Интернациональ Гмбх Viral polymerase inhibitors
US7348425B2 (en) 2004-08-09 2008-03-25 Bristol-Myers Squibb Company Inhibitors of HCV replication
EP1844042A1 (en) * 2005-01-14 2007-10-17 Genelabs Technologies, Inc. Indole derivatives for treating viral infections
CA2597680A1 (en) * 2005-02-11 2006-08-17 Boehringer Ingelheim International Gmbh Process for preparing 2,3-disubstituted indoles
EP1881828A4 (en) * 2005-05-20 2009-06-03 Valeant Res & Dev TREATMENT OF HEPATITIS C (HCV) USING SUB-THERAPEUTIC DOSES OF RIBAVIRIN
CA2618682C (en) 2005-08-12 2011-06-21 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
US7816348B2 (en) 2006-02-03 2010-10-19 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
WO2007092000A1 (en) * 2006-02-06 2007-08-16 Bristol-Myers Squibb Company Inhibitors of hcv replication
GB0608928D0 (en) 2006-05-08 2006-06-14 Angeletti P Ist Richerche Bio Therapeutic agents
JP2010500978A (ja) 2006-08-17 2010-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスポリメラーゼインヒビター
FR2910813B1 (fr) 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
WO2009008906A2 (en) 2007-02-06 2009-01-15 The Trustees Of The University Of Pennsylvania Therapeutic compounds for blocking dna synthesis of pox viruses
CA2686051A1 (en) 2007-05-04 2008-11-13 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of hcv infection
WO2009010783A1 (en) 2007-07-17 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Macrocyclic indole derivatives for the treatment of hepatitis c infections
JP2010535156A (ja) 2007-08-03 2010-11-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスポリメラーゼ阻害剤
US20100286131A1 (en) * 2007-08-03 2010-11-11 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
WO2009076173A2 (en) 2007-12-05 2009-06-18 Enanta Pharmaceuticals, Inc. Fluorinated tripeptide hcv serine protease inhibitors
EP2234977A4 (en) 2007-12-19 2011-04-13 Boehringer Ingelheim Int VIRAL POLYMERASE INHIBITORS
JP2012514605A (ja) 2009-01-07 2012-06-28 サイネクシス，インコーポレーテッド Ｈｃｖおよびｈｉｖ感染の治療への使用におけるシクロスポリン誘導体
WO2010114896A1 (en) 2009-03-31 2010-10-07 Arqule, Inc. Substituted indolo-pyridinone compounds
EP2429568B1 (en) 2009-05-13 2016-08-17 Enanta Pharmaceuticals, Inc. Macrocyclic compounds as hepatitis c virus inhibitors
US8648037B2 (en) 2010-09-21 2014-02-11 Enanta Pharmaceuticals, Inc. Macrocyclic proline derived HCV serine protease inhibitors
US9233921B2 (en) 2013-03-08 2016-01-12 The Trustees Of The University Of Pennsylvania Potent poxvirus inhibitor
CN113444094B (zh) * 2016-07-20 2023-12-22 纳莹(上海)生物科技有限公司 一种荧光探针及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
IL157280A0 (en) 2001-03-08 2004-02-19 Boehringer Ingelheim Ca Ltd Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
JP4558314B2 (ja) 2001-07-20 2010-10-06 ベーリンガー インゲルハイム （カナダ） リミテッド ウイルスポリメラーゼインヒビター
EP2335700A1 (en) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors

Also Published As

Publication number Publication date
WO2006007693A1 (en) 2006-01-26
KR20070035092A (ko) 2007-03-29
EA200700038A1 (ru) 2007-08-31
US7241801B2 (en) 2007-07-10
AU2005263135A1 (en) 2006-01-26
UY29017A1 (es) 2006-02-24
ZA200609578B (en) 2008-08-27
TW200617003A (en) 2006-06-01
EP1771442A4 (en) 2009-12-30
CA2573210A1 (en) 2006-01-26
EP1771442A1 (en) 2007-04-11
AR050172A1 (es) 2006-10-04
JP2008506638A (ja) 2008-03-06
CN1984908A (zh) 2007-06-20
NO20070368L (no) 2007-01-30
BRPI0513431A (pt) 2008-05-06
US20070249629A1 (en) 2007-10-25
US20060052418A1 (en) 2006-03-09
ECSP077171A (es) 2007-02-28
IL180665A0 (en) 2007-06-03
MX2007000007A (es) 2007-03-07

Similar Documents

Publication Publication Date Title
PE20060569A1 (es) Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc
PE20141120A1 (es) Compuestos heterociclicos
PE20080702A1 (es) PROLINAMIDAS SUSTITUIDAS COMO INHIBIDORES DEL FACTOR Xa
PE20060481A1 (es) N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas
PE20140502A1 (es) Pirimidinas sustituidas de diaminocarboxamida y diaminocarbonitrilo, composiciones de las mismas y metodos de tratamiento con las mismas
PE20121157A1 (es) Compuestos heterociclicos como inhibidores de proteasas serinas
PE20081344A1 (es) Inhibidores del virus de la hepatitis c
PE20091002A1 (es) Analogos dipeptidos como inhibidores del factor de coagulacion
PE20110067A1 (es) Derivados de piperidina como inhibidores de renina
CL2011000689A1 (es) Compuesto derivado de ((4-terbutilfenil)pirrolidin-2,5-diil)bis(4,1-fenilen)sustituido, inhibidor de la replicacion del vhc; composicion farmaceutica; util en el tratamiento de una infeccion por vhc.
PE20081505A1 (es) Inhibidores de serina palmitoiltransferasa
PE20141375A1 (es) Activadores de glucoquinasa
DE60316416D1 (de) Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
ATE527259T1 (de) Kondensierte aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20110598A1 (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
PE20121354A1 (es) Inhibidores del virus de la hepatitis c
PE20070804A1 (es) Compuestos heterociclicos como inhibidores de proteasa aspartica
PE20090813A1 (es) Inhibidores de la 11b-hidroxiesteroide-deshidrogenasa
HRP20110640T1 (hr) Derivati cikličkih amida i njihova proizvodnja te njihova uporaba kao antitromboznih sredstava
PE20081353A1 (es) Compuestos del inhibidor de fosfoinositida 3-cinasa
DE602004026440D1 (de) Kondensierte indole als dipeptidyl-peptidase-hemmer zur behandlung oder prävention von diabetes
PE20080951A1 (es) DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
AR066972A1 (es) Derivados azapeptidicos
AR077765A1 (es) Inhibidores de los virus flaviviridae

Legal Events

Date Code Title Description
FC Refusal